Association between cyclo-oxygenase-2 overexpression and missense p53 mutations in gastric cancer.
about
Association of the MDM2 SNP285 Polymorphism with Cancer Susceptibility: A Meta-AnalysisCyclooxygenase-2 and gastric carcinogenesisExpression of cyclooxygenase-2, p53 and Ki-67 in gastric cancerExpression of 15-PGDH is downregulated by COX-2 in gastric cancer.Induction of cyclooxygenase-2 expression by interleukin-1beta in human glioma cell line, U87MG.MMP-2 but not MMP-9 associated with COX-2 and survival in gastric cancer.Prognostic significance of expression of cysteine-rich 61 and cyclooxygenase-2 in gastric cancer.Pathogenesis of pre-neoplastic lesions of the stomach: targets for prevention.Expression of cyclooxygenase-2 and clinicopathologic features in human gastric adenocarcinoma.The roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signaling mechanismsIncreased expression of survivin in gastric cancer patients and in first degree relativesTopical diclofenac in the treatment of actinic keratoses.Cyclooxygenase inhibitors: scope of their use and development in cancer chemotherapy.Cyclooxygenase-2 and gastric cancer.Cyclooxygenase-2 expression is associated with poor overall survival of patients with gastric cancer: a meta-analysis.Meloxicam inhibits fipronil-induced apoptosis via modulation of the oxidative stress and inflammatory response in SH-SY5Y cells.Clinical and prognosis relevance of COX-2 expression in Tunisian patients with primary gastric adenocarcinoma.COX-2 and survivin reduction may play a role in berberine-induced apoptosis in human ductal breast epithelial tumor cell line.Anti-cancer activity of anti-p185HER-2 ricin A chain immunotoxin on gastric cancer cells.15-Deoxy-Delta(12,14)-prostaglandin J(2) stabilizes, but functionally inactivates p53 by binding to the cysteine 277 residue.Different cell kinetic changes in rat stomach cancer after treatment with celecoxib or indomethacin: implications on chemopreventionImmunohistochemical study of cyclooxygenase-2 and p53 expression in skin tumors.Chemoprevention of gastric cancer by celecoxib in rats.Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran.Quantitative measurement of m-RNA levels to assess expression of cyclooxygenase-II, inducible nitric oxide synthase and 12-lipoxygenase genes in middle ear cholesteatoma.Expression of cyclooxygenase-2 in chronic hepatitis B and the effects of anti-viral therapy.Functional loss of p53 cooperates with the in vivo microenvironment to promote malignant progression of gastric cancers.Cyclooxygenase-2 expression during carcinogenesis in the human stomach.
P2860
Q28066326-6EDF24FB-9731-43AB-B33A-D3BC9CC5D025Q28184447-2AEA9A78-F499-4F72-B43B-65E24B9B8819Q28200724-6508AC2D-6821-49B2-B7E7-2CF19896E2A7Q33313240-11CC2534-FE58-481C-BB94-0A55BF9E6FBEQ33943485-A760B029-CEB1-483C-A293-BF4F0BFF90A0Q35770018-870CF999-FAB9-4C76-ADF3-07F518B22EAAQ36085411-8817CD79-2373-47AF-B112-A6AD5A052480Q36090018-16E8B46B-1C26-4F5A-9122-1CAC51A3FCB5Q36178297-20E1848B-1DDE-4DF5-B402-9E33791A39C2Q36500327-B72EC193-22A8-4128-B946-F28E9847D98FQ36624221-EBC2BAAA-66B5-4187-BCD6-B1FAA7291F23Q36703886-B2F7CA16-BD98-4CFF-B7A6-5F2D72022FE5Q37646513-858FE7BE-A537-42B5-9EF0-3248CFDF0239Q37946290-C5D31856-662D-45D2-9A29-44990A4C4960Q38157778-191B03BA-3592-45D2-AB9D-8487CE7C45EFQ38899764-349D447D-FEFE-4EF3-ABC4-8D6471F80984Q38901848-1D8C9424-EBBA-4907-8C48-C56D1640037AQ39443482-6D1CE92F-0A6A-4F4A-8299-EE2DF2DDDACCQ39686196-437620EC-F7C5-4EC3-9117-0063A1CB5535Q39731280-2E55F15E-6A0F-4B7F-8F11-E3C4C09D26B6Q42017681-412E6588-D13E-4064-A492-EBC5EFE52BB0Q42495389-751A2278-F150-4BD4-9F57-5EC01B721871Q43003893-68490FB3-AF9F-42EB-9CFF-25C40E483A35Q43796922-5B4775B7-ACB8-477F-AD02-A938B146B197Q43802965-2909835B-3B41-4EF4-8D1B-9FEC688ED825Q43892507-021C7B04-7C27-4A1A-B5F1-3D84FBF1EB9DQ49192331-E56D48E7-1179-4EAF-BC9E-A78FC21450ADQ53393003-F31678FE-630F-41A8-86A3-244F8024083A
P2860
Association between cyclo-oxygenase-2 overexpression and missense p53 mutations in gastric cancer.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Association between cyclo-oxyg ...... 3 mutations in gastric cancer.
@ast
Association between cyclo-oxyg ...... 3 mutations in gastric cancer.
@en
type
label
Association between cyclo-oxyg ...... 3 mutations in gastric cancer.
@ast
Association between cyclo-oxyg ...... 3 mutations in gastric cancer.
@en
prefLabel
Association between cyclo-oxyg ...... 3 mutations in gastric cancer.
@ast
Association between cyclo-oxyg ...... 3 mutations in gastric cancer.
@en
P2093
P2860
P50
P356
P1476
Association between cyclo-oxyg ...... 53 mutations in gastric cancer
@en
P2093
P2860
P2888
P304
P356
10.1054/BJOC.2000.1607
P407
P577
2001-02-01T00:00:00Z
P5875
P6179
1029472727